This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
UnitedHealth Continues Healthcare Shakeup With DaVita Deal
by Benjamin Rains
On Wednesday, only a few days after the CVS (CVS) and Aetna (AET) deal helped shine a light on the quickly changing healthcare industry, UnitedHealth Group (UNH) announced that it will buy a unit of DaVita Inc. (DVA) for nearly $5 billion.
CVS-Aetna Deal: What's Hot, What's Not
by Zacks Equity Research
CVS Health (CVS) and Aetna consolidation to add a new dimension to healthcare landscape. However, critics believe the gain will be short-lived for the healthcare society.
The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics
by Zacks Equity Research
The Zacks Analyst Blog Highlights: CVS Health, Aetna, PetMed Express, Align Technology and Myriad Genetics
The Zacks Analyst Blog Highlights: Alibaba, Aetna, 21st Century Fox, Adobe and Pioneer Natural Resources
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Alibaba, Aetna, 21st Century Fox, Adobe and Pioneer Natural Resources
3 Healthcare Stocks to Buy After CVS & Aetna Deal
by Benjamin Rains
The healthcare industry is headed for a shakeup after CVS Health (CVS) officially announced its purchase of healthcare benefits giant Aetna (AET) on Monday.
Dow Futures Up Above 200 Points In Pre-Market
by Zacks Equity Research
Dow Futures Up Above 200 Points In Pre-Market
Will Tax Cut Passage Be Easy?
by Mark Vickery
Dow futures have rocketed up more than 200 points in this morning's pre-market on news that the Senate has passed its version of a tax reform bill in the wee hours of Saturday morning.
Aetna, CVS Health Ink a Merger Agreement Worth $69 Billion
by Zacks Equity Research
Aetna's (AET) acquisition by CVS Health promises to expand the former's scale and size, and improve its access to health at lower cost.
Will the Healthcare Landscape Change with the $69B CVS-Aetna Deal?
by Arpita Dutt
Will the $69 billion CVS Health (CVS)-Aetna acquisition trigger more such deals in the healthcare sector?
Will Aetna Be Acquired by CVS Health to Rest Speculations?
by Zacks Equity Research
Aetna's (AET) likely acquisition by CVS Health promises to improve the company's scale and size, thus allowing it to better negotiate over drug prices.
Humana's Medicare Business Impresses, Public Exchange Hurts
by Zacks Equity Research
Although Humana (HUM) continues to grow on the back of Medicare and Medicaid expansions, threats from its exchange business weigh on both revenues and margins.
Can Health Insurers Continue to Look Past ACA Threats in Q4?
by Zacks Equity Research
Despite regulatory challenges, health insurance companies have the potential to outperform in Q4 on growing demand for government plans, reduced uninsured rates and aging U.S. population.
Anthem (ANTM) Grows on Membership, Rising Expenses Hurt
by Zacks Equity Research
Anthem's (ANTM) revenues gain from solid membership base and rising net investment income. However, public exchange loss and rising expenses continue to bother.
Tenet Healthcare's (THC) Q3 Loss Narrower Than Expected
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter results were affected by lower revenues and higher expenses.
Can Retail Segment Further Drive Humana's (HUM) Q3 Earnings?
by Zacks Equity Research
Humana's (HUM) third-quarter results are likely to be driven by strong performance of its Retail segment.
Molina Healthcare (MOH) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter earnings were driven by solid revenue growth.
Cigna (CI) Q3 Earnings Beat on Higher Enrollment, Guides Up
by Zacks Equity Research
Cigna's (CI) strong third-quarter earnings were driven by broad-based growth across its business segments.
Teladoc (TDOC) Q3 Loss Wider Than Expected, Revenues Top
by Zacks Equity Research
Teladoc's (TDOC) third-quarter revenues grew year over year on higher visits.
Company News For Nov 1, 2017
by Zacks Equity Research
Companies in the news are: PFE, UA,AET, ACOR
Envision Healthcare's (EVHC) Q3 Earnings Miss Expectations
by Zacks Equity Research
Envision Healthcare's (EVHC) third-quarter results were adversely impacted by hurricanes Harvey and Irma.
WellCare Health's (WCG) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
WellCare Health's (WCG) third-quarter results were driven by membership growth.
Aetna (AET) Tops Q3 Earnings Estimates, Raises 2017 Guidance
by Zacks Equity Research
Aetna's (AET) solid third-quarter results were largely driven by continued strong performance in the company's Health Care segment.
Aetna's (AET) Q3 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Aetna's (AET) third quarter earnings surpass our expectations and grows year over year.
Will Increased Visits Drive Teladoc's (TDOC) Q3 Earnings?
by Zacks Equity Research
Teladoc's (TDOC) earnings will benefit from its premier consumer engagement capabilities, broad network and scalable platform, which will increase visits and clients.
Illinois Tool Works, HNI, CVS Health, Aetna and Amazon.com highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Illinois Tool Works, HNI, CVS Health, Aetna and Amazon.com highlighted as Zacks Bull and Bear of the Day